Lasofoxifene in Postmenopausal Women with Osteoporosis
Author(s) -
Steven R. Cummings,
Kristine E. Ensrud,
Pierre D. Delmas,
Andrea Z. LaCroix,
Slobodan Vukičević,
David M. Reid,
Steven R. Goldstein,
Usha Sriram,
Andy Lee,
John R. Thompson,
Róisín Armstrong,
David D. Thompson,
Trevor J. Powles,
José Zanchetta,
David L. Kendler,
Patrick Neven,
Richard Eastell
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0808692
Subject(s) - medicine , osteoporosis , breast cancer , postmenopausal women , disease , oncology , gynecology , cancer
The effects of lasofoxifene on the risk of fractures, breast cancer, and cardiovascular disease are uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom